Company profile
RetinalGenix Technologies Inc. CIK 1836295
Ticker
RTGN (OTC)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Petaluma, CA 94954
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$2.43M
Total assets
$21.0K
Total liabilities
$2.32M
Stockholders' equity
-$2.30M
Cash & equivalents
—
Operating income
—
Operating cash flow
-$558.4K
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-04-15. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
11,043.4%
Equity / assets
-10,943.4%
CapEx / revenue
—
Operating cash flow / net income
0.23×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$2.43M
$21.0K
$2.32M
-$2.30M
2024
—
-$4.32M
$14.9K
$1.48M
-$1.46M
2023
—
-$2.09M
$156
$1.41M
-$1.41M
2022
—
-$3.91M
$294
$1.07M
-$1.07M
2021
—
-$2.18M
$4.9K
$469.6K
-$464.7K
Company Details
SIC code
3841
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-14
Financials filed via
Form 10-K
filed 2026-04-15
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Petaluma, CA 94954
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.